CAPRIOLI, FLAVIO ANDREA

CAPRIOLI, FLAVIO ANDREA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 249 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitis 2026 Caprioli, Flavio APastorelli, LucaNoviello, Daniele + Article (author) -
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 2026 Aloi, MarinaCaprioli, FlavioPastorelli, Luca + Article (author) -
The long game in ulcerative colitis: mirikizumab's four-year outcomes 2026 Noviello, DanieleCaprioli, Flavio Article (author) -
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care 2026 Privitera, GiuseppeCaprioli, Flavio + Article (author) -
The assessment of multidimensional clinical, biological and patient-reported outcomes to evaluate the efficacy of add-on Lactobacillus rhamnosus GG supplementation in mild ulcerative colitis: a randomized pilot trial 2026 Noviello, DanieleCaprioli, FlavioVecchi, Maurizio + Article (author) -
Early recognition of peripheral spondyloarthritis in inflammatory bowel disease: A prospective observational study integrating detail questionnaire screening, ultrasound-based diagnosis, and gut microbiota profiling 2026 Santagata, FabrizioFerrito, MatteoFavalli, Ennio GiulioCaporali, RobertoDe Lucia, OrazioConforti, FrancescoO Sed, Nicole PiazzaSpina, LuisaCaridi, BrunaTrignani, GiorgiaIngrao, LucaVecchi, MaurizioCaprioli, Flavio + Article (author) -
Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel 2025 Caprioli, FlavioElli, Luca + Article (author) -
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 2025 Caprioli, Flavio + Article (author) -
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 2025 Pastorelli, LucaCaprioli, Flavio + Article (author) -
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey 2025 Caprioli, Flavio Andrea + Article (author) -
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class 2025 Caprioli, FlavioNoviello, Daniele + Article (author) -
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease 2025 Caprioli, Flavio AndreaPastorelli, Luca + Article (author) -
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular Dystrophy 2025 Mostosi D.Cassani B.Caprioli F.Torrente Y. + Article (author) -
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies-Insights from the IUS IG-IBD Master Program 2025 Maconi, GiovanniCaprioli, Flavio + Article (author) -
Different survival outcomes of small bowel adenocarcinomas and T-cell lymphomas associated to celiac disease 2025 Santacroce G.Lenti M. V.Elli L.Libera L.Sampietro G.Ardizzone S.Ferrero S.Tonelli F.Monteleone G.Caprioli F.Vecchi M.Oreggia B.Silano M.Massironi S.Biagi F. + Article (author) -
The Dedicated Inflammatory Bowel Disease Nurse, If You Know Them, You Love Them: Survey of the Italian IBD Patients' Association 2025 Caprioli, Flavio + Article (author) -
Assessment of nutritional status and eating behaviours in patients with chronic inflammatory bowel disease: a pilot study 2025 Elli, LucaCostantino, AndreaCaprioli, FlavioTontini, Gian EugenioVecchi, MaurizioDoneda, LuisaRoncoroni, Leda + Article (author) -
AIEC-derived LPS and Outer Membrane Vesicles differently drive the dysregulated immunological pathways linked to Crohn’s Disease 2025 IRENE DUSETTIFLAVIO CAPRIOLIPAOLO LANDINIALESSANDRA POLISSIPAOLA SPERANDEOMOIRA PARONI + Book Part (author) -
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 2025 D. NovielloM. VecchiF. Caprioli + Article (author) -
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study 2025 Caprioli, Flavio Andrea + Article (author) -